Cambridge Investment Research Advisors Inc. boosted its holdings in Journey Medical Corporation (NASDAQ:DERM – Free Report) ...

A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of ...

Routine SLNB may be used to predict tumor invasion levels and SLN metastasis in patients with EMPD who do not have enlarged lymph nodes.

What’s something you wish more women knew about their skin health? I wish women knew how important sunscreen is in their ...

A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in collaboration with the Faculty of Engineering at ...

The abundance in Black skin of melanin, the pigment that gives skin its color, offers extra protection from damaging ...

How DERM works. For lesions identified as pre-cancerous or cancerous, an NHS dermatologist reviews the case virtually and determines the appropriate management plan. For patients with black or brown ...

3 Committee discussion. The diagnostics advisory committee considered evidence on Deep Ensemble for Recognition of Malignancy (DERM) to assess and triage skin lesions referred to the urgent suspected ...

A high-level overview of Journey Medical Corporation (DERM) stock. View (DERM) real-time stock price, chart, news, analysis, analyst reviews and more.

DERM (Deep Ensemble for Recognition of Malignancy), which was approved in the UK as a Class IIA medical device in 2022, analyses images to assess and triage skin lesions, and may be able to refer ...

DERM provides a suspected diagnosis and triages the case. Patients with benign lesions may be redirected to non-urgent pathways and receive written safety-netting advice. Suspicious lesions are ...